Pharma Aids Statistics

Total Valuation

Pharma Aids has a market cap or net worth of BDT 1.52 billion. The enterprise value is 1.50 billion.

Market Cap	1.52B
Enterprise Value	1.50B

Important Dates

The last earnings date was Sunday, April 27, 2025.

Earnings Date	Apr 27, 2025
Ex-Dividend Date	Dec 8, 2024

Share Statistics

Pharma Aids has 3.12 million shares outstanding.

Current Share Class	3.12M
Shares Outstanding	3.12M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 28.71.

PE Ratio	28.71
Forward PE	n/a
PS Ratio	3.66
PB Ratio	3.65
P/TBV Ratio	3.65
P/FCF Ratio	n/a
P/OCF Ratio	6,671.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.59, with an EV/FCF ratio of -463.23.

EV / Earnings	28.34
EV / Sales	3.61
EV / EBITDA	18.59
EV / EBIT	20.21
EV / FCF	-463.23

Financial Position

The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.06.

Current Ratio	3.00
Quick Ratio	1.30
Debt / Equity	0.06
Debt / EBITDA	0.29
Debt / FCF	-7.15
Interest Coverage	62.45

Financial Efficiency

Return on equity (ROE) is 14.03% and return on invested capital (ROIC) is 11.87%.

Return on Equity (ROE)	14.03%
Return on Assets (ROA)	8.95%
Return on Invested Capital (ROIC)	11.87%
Return on Capital Employed (ROCE)	17.71%
Revenue Per Employee	4.85M
Profits Per Employee	617,277
Employee Count	86
Asset Turnover	0.80
Inventory Turnover	4.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.48% in the last 52 weeks. The beta is -0.01, so Pharma Aids's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-35.48%
50-Day Moving Average	536.42
200-Day Moving Average	601.78
Relative Strength Index (RSI)	33.08
Average Volume (20 Days)	14,879

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Aids had revenue of BDT 416.81 million and earned 53.09 million in profits. Earnings per share was 17.01.

Revenue	416.81M
Gross Profit	120.72M
Operating Income	74.42M
Pretax Income	74.30M
Net Income	53.09M
EBITDA	80.92M
EBIT	74.42M
Earnings Per Share (EPS)	17.01

Full Income Statement

Balance Sheet

The company has 43.00 million in cash and 23.23 million in debt, giving a net cash position of 19.77 million or 6.34 per share.

Cash & Cash Equivalents	43.00M
Total Debt	23.23M
Net Cash	19.77M
Net Cash Per Share	6.34
Equity (Book Value)	417.85M
Book Value Per Share	133.93
Working Capital	326.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 228,450 and capital expenditures -3.48 million, giving a free cash flow of -3.25 million.

Operating Cash Flow	228,450
Capital Expenditures	-3.48M
Free Cash Flow	-3.25M
FCF Per Share	-1.04

Full Cash Flow Statement

Margins

Gross margin is 28.96%, with operating and profit margins of 17.85% and 12.74%.

Gross Margin	28.96%
Operating Margin	17.85%
Pretax Margin	17.83%
Profit Margin	12.74%
EBITDA Margin	19.41%
EBIT Margin	17.85%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.50%.

Dividend Per Share	2.50
Dividend Yield	0.50%
Dividend Growth (YoY)	150.00%
Years of Dividend Growth	1
Payout Ratio	14.77%
Buyback Yield	n/a
Shareholder Yield	0.50%
Earnings Yield	3.48%
FCF Yield	-0.21%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Pharma Aids has an Altman Z-Score of 9.73.

Altman Z-Score	9.73
Piotroski F-Score	n/a